OIMU
DXCM icon

Osmosis Investment Management UK’s DexCom DXCM Stock Holding History

Osmosis Investment Management UK’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Sell
9,635
-437
-4% -$29.1K 0.03% 321
2026
Q1 		$633K Buy
10,072
+1,095
+12% +$76.3K 0.02% 376
2025
Q4 		$596K Buy
+8,977
New +$580K 0.02% 324

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Osmosis Investment Management UK's DXCM Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its DexCom (DXCM) stake by 4.3% in Q2 2026, selling an estimated $29.1K and leaving 9,635 shares worth $649K. The position accounts for 0.03% of the portfolio, ranked #321.

Osmosis Investment Management UK first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Osmosis Investment Management UK held 9,635 shares of DexCom worth $649K as of Q2 2026.
  • Osmosis Investment Management UK sold 437 DexCom shares in Q2 2026, an estimated $29.1K.
  • DexCom made up 0.03% of Osmosis Investment Management UK's portfolio in Q2 2026, its #321 holding.
  • Osmosis Investment Management UK first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.